- Home
- FCEL vs VNDA Comparison
FCEL vs VNDA Comparison
Compare FCEL & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCEL
- VNDA
- Stock Information
- Founded
- FCEL 1969
- VNDA 2002
- Country
- FCEL United States
- VNDA United States
- Employees
- FCEL N/A
- VNDA N/A
- Industry
- FCEL Industrial Machinery/Components
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- FCEL Energy
- VNDA Health Care
- Exchange
- FCEL Nasdaq
- VNDA Nasdaq
- Market Cap
- FCEL 273.9M
- VNDA 260.0M
- IPO Year
- FCEL 1992
- VNDA 2006
- Fundamental
- Price
- FCEL $7.06
- VNDA $4.36
- Analyst Decision
- FCEL Hold
- VNDA Strong Buy
- Analyst Count
- FCEL 4
- VNDA 3
- Target Price
- FCEL $8.91
- VNDA $14.00
- AVG Volume (30 Days)
- FCEL 3.5M
- VNDA 668.5K
- Earning Date
- FCEL 12-18-2025
- VNDA 10-29-2025
- Dividend Yield
- FCEL N/A
- VNDA N/A
- EPS Growth
- FCEL N/A
- VNDA N/A
- EPS
- FCEL N/A
- VNDA N/A
- Revenue
- FCEL $152,472,000.00
- VNDA $212,074,000.00
- Revenue This Year
- FCEL $34.50
- VNDA $14.32
- Revenue Next Year
- FCEL $25.64
- VNDA $37.05
- P/E Ratio
- FCEL N/A
- VNDA N/A
- Revenue Growth
- FCEL 78.81
- VNDA 11.12
- 52 Week Low
- FCEL $3.58
- VNDA $3.81
- 52 Week High
- FCEL $13.98
- VNDA $5.70
- Technical
- Relative Strength Index (RSI)
- FCEL 42.76
- VNDA 34.76
- Support Level
- FCEL $6.98
- VNDA $4.35
- Resistance Level
- FCEL $7.76
- VNDA $4.48
- Average True Range (ATR)
- FCEL 0.81
- VNDA 0.20
- MACD
- FCEL -0.14
- VNDA -0.05
- Stochastic Oscillator
- FCEL 14.82
- VNDA 5.59
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.